Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
When to use bispecifics for AML
Can we cure 50% of all multiple myeloma patients in the next five years?
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.